After Taking Diabetes Drug Actos for Nearly Seven Years, Florida Man Developed Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP

Share Article

The Type 2 diabetes drug Actos (pioglitazone) caused a Florida man’s bladder cancer, Parker Waichman LLP alleges in a lawsuit it has filed. An additional claim in the lawsuit — one of thousands filed as part of a multidistrict litigation in Louisiana — is that the manufacturer knew of the drug’s risks but failed to reveal them to the public.

News Image
According to the Complaint, the Plaintiff started ingesting Actos in August, 2005, through July, 2012, which is when he started to suffer from bladder cancer, allegedly due to his use of Actos.

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused a Florida man to develop bladder cancer. The suit was filed on Aug. 15, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-2485). It is one of thousands of cases filed as part of the multidistrict litigation (MDL) entitled In Re: Actos (pioglitazone) Products Liability Litigation (6:11-md-2299). Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee.

According to the Complaint, the Plaintiff started ingesting Actos in August, 2005, through July, 2012, which is when he started to suffer from bladder cancer, allegedly due to his use of Actos. The U.S. Food and Drug Administration (FDA) has warned about the risks of taking Actos. On June 15, 2011, the agency said that taking the diabetes drug for more than a year could significantly increase the risk of bladder cancer. The FDA also noted that the safety label for Actos had been updated to address this risk.

Some research studies provide additional support to help buttress claims that a link exists between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012, that revealed Actos users were twice as likely to develop bladder cancer after two years. Then, on July 3, 2012, the Canadian Medical Association Journal reported that patients taking the medication were 22 percent more likely to develop bladder cancer.

Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:    
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Parker Waichman LLP

Follow us on
Visit website